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Sarcomatoid transitional cell carcinoma (TCC) of the renal pelvis is an extremely rare tumor and accounts for 0.3% of all urothelial carcinomas [1] with sarcoma-like components 
arising from the malignant transitional epithelium and shows 
aggressive behavior. Due to its rarity, there are only a few studies 
concerning the treatment efficacy of sarcomatoid TCC. At present, 
surgical resection remains the first line of treatment.
Collecting duct carcinoma (CDC) is another rare histological 
variant of renal cell carcinoma (RCC), arising from the epithelium 
of distal collecting ducts, also called Bellini duct cell carcinoma. 
It represents approximately 2% of all the RCCs and is highly 
aggressive [2]. We, herein, report the clinical and pathological 
features of one case each of sarcomatoid TCC and CDC.
CASE REPORT
Case 1
A 65-year-old male patient presented with intermittent hematuria 
and the left flank pain for 6 months duration. On physical 
examination, the vitals were stable and there was no palpable 
abdominal mass. The computed tomography (CT) scan revealed 
an ill-defined lesion in the pelvis of the left kidney (Fig. 1a) and 
a left laparoscopic nephroureterectomy was performed. The gross 
picture showed that the nephrectomy specimen measured 9 cm×7 
cm×5 cm, along with perinephric fat and ureter of length 10 cm. Cut 
section showed an ill-defined gray-white to tan, firm lesion, with 
some friable areas, in the pelvicalyceal region, measuring 5 cm in 
greatest dimension (Fig. 1b). No lymph nodes were identified.
Microscopic examination showed a tumor composed of 
two components: Invasive TCC (Fig. 2a and b) and spindle 
cell area with some bizarre cells (Fig. 2c), matrix-like material, 
and many osteoclastic types of giant cells (Fig. 2d). The 
adjacent kidney showed chronic glomerulonephritis changes. 
Immunohistochemistry was diffusely positive for CK7 in both the 
components and negative for CK20 and p63, indicating epithelial 
origin. A diagnosis of sarcomatoid TCC of renal pelvis was made. 
No adjuvant chemotherapy was given. A follow-up was done 
after 12 months of surgery, and the patient had no complaints and 
was disease free.
Case 2
A 72-year-old male presented with the left side flank pain and 
three episodes of hematuria, in 2 weeks period. On physical 
examination, the vitals were stable and there was mild tenderness 
of the left flank with no palpable mass. The CT scan revealed an 
ill-defined, low-attenuation lesion, located in the renal medulla of 
the left kidney. He underwent the left-sided nephroureterectomy, 
with a pre-operative diagnosis of T2N0M0.
A gross picture showed the nephrectomy specimen (Fig. 3a) 
measured 15 cm×8 cm×5 cm, along with perinephric fat and 
ureter of length 5 cm. Cut sections showed a gray-white to tan 
lesion at the confluence of medulla and cortex with irregular 
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outline and are infiltrating into the perinephric fat, at the pelvis. 
The renal capsule showed adhesions in some areas. Microscopic 
examination showed a tumor with tubule-papillary morphology 
accompanied by marked desmoplasia (Fig. 3b and c). The lining 
epithelium of the adjacent collecting ducts showed cytological 
atypia (Fig. 3d), suggesting a diagnosis of CDC of the kidney. 
Adjuvant chemotherapy or radiotherapy was not given. 
A follow-up done after 2½ years showed that the patient was 
disease free and without recurrence.
DISCUSSION
Sarcomatoid carcinoma is a high-grade epithelial neoplasm 
characterized by a biphasic appearance with epithelial component 
and another area with a sarcoma-like appearance. Carcinosarcoma 
is a term frequently confused with sarcomatoid carcinoma, which 
consists of a malignant epithelial component and specific features 
of mesenchymal differentiation, such as chondrosarcoma, 
osteosarcoma, and liposarcoma. Due to similar morphologies in 
microscopic appearance with hematoxylin and eosin staining, 
immunohistochemistry is necessary for a diagnosis.
TCC is the most common type of malignancy occurring in the 
renal pelvis. However, a sarcomatoid variant of TCC is extremely 
rare. Perez-Montiel et al. [3] studied 108 cases of high-grade 
urothelial carcinomas and only eight were sarcomatoid TCCs, with 
the advanced involvement of parenchyma and very poor prognosis 
with a mean survival time of 11.2 months. Adjuvant chemotherapy 
offered no response. Froehner et al. [4] suggested that it would be 
appropriate to treat these tumors in the same manner as conventional 
high-grade TCC, with the gemcitabine-based regime.
In a retrospective study by Chen et al., [5] among eight 
cases diagnosed as renal pelvis sarcomatoid carcinoma, all were 
males and the majority presented with intermittent hematuria. 
Radiological findings showed a tumor in the renal pelvis. On 
gross examination, the mean tumor size was 5.8±4.5 cm. Of eight 
patients, six succumbed to the disease while two patients were 
free of disease at 54 and 120 months, respectively. The present 
case of sarcomatoid variant of TCC is also a male 65 years, 
presenting with hematuria and tumor of size 5 cm greatest 
dimension in the renal pelvis. The patient remains disease free, 
12 months after laparoscopic nephroureterectomy and without 
adjuvant chemotherapy.
CDC is a rare and an unusual variant of RCC. Cheville et al. [6] 
studied 2385 patients, whose first surgery between 1970 and 2000 
was a radical nephrectomy for sporadic unilateral RCC, which 
included only 6 cases (0.3%) of CDC. The first report that the 
ducts of Bellini could give rise to tumors was made by the findings 
of atypical hyperplastic change in the collecting duct epithelium, 
distant from a renal papillary tumor [3]. Later, it has been grouped 
in RCC with a subdesignation “Bellini duct carcinoma” in an 
international classification of tumors by the WHO [7]. Since then 
just over 100 cases have been describes [8]. Criteria for diagnosing 
CDC are central location, irregular tubular architecture, high-
nuclear grade, reactive with high-molecular-weight cytokeratin, 
inflammatory desmoplastic stroma, and extensive renal, extrarenal, 
and lymphovascular infiltration [7]. The typical CDC has a poor 
prognosis with many being metastatic at presentation. About two-
thirds of patients die of their disease within 2 years of diagnosis [9].
In a study by Wilson Sui et al. [10], among 2016, 86 cases 
of RCC, there were 577 cases of CDC and they presented with 
Figure 2: (a) Invasive transitional cell carcinoma (TCC) component, 
H and E, ×10; (b) TCC, H and E, ×40; (c) tumor with spindle cell 
areas, infiltrating into adjacent kidney parenchyma, glomerulus , 
H and E, ×10; (d) tumor with osteoclastic type of giant cells, in 
spindle cell areas, H and E, ×10
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Figure 1: (a) Computed tomography scan picture showing the left 
kidney lesion; (b) gross picture of the left nephrectomy specimen 
along with perinephric fat
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Figure 3: (a) Gross picture showing cut section of the left 
nephroureterectomy specimen; (b) tumor with tubulopapillary 
patterns, infiltrating into the adjacent renal parenchyma, shows 
glomerulus, H and E, ×10; (c) tumor with inflammatory desmoplastic 
stroma, H and E, ×10; (d) tumor cells with marked pleomorphism, 
H and E, ×40
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higher grade and stage, node positive, and metastatic disease. 
Overall, median survival for CDC was 13.2 months compared to 
122.5 months for clear cell RCC. They concluded that CDC is 
an aggressive subtype of RCC and adjuvant chemoradiation after 
nephrectomy showed survival benefit over single-mode therapy. 
In the present case, the tumor is at the confluence of medulla 
and cortex, with tubulo-papillary patterns, of high nuclear 
grade and extensive desmoplasia. The tumor shows infiltration 
into perinephric fat and is labelled as CDC of kidney-papillary 
type. The patient succumbed to disease 26 months after radical 
nephroureterectomy, without any adjuvant chemotherapy.
CONCLUSION
Sarcomatoid TCC of the renal pelvis and CDC of the kidney are 
very rare high-grade neoplasms with a very poor prognosis. For 
early localized disease, a radical, aggressive operation should 
be considered to improve the outcomes. However, systemic 
chemotherapy with a gemcitabine-based regimen may be offered 
for sarcomatoid TCC, due to its urothelial origin.
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